about
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae.High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin.Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally.Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011.Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeaeEvaluation of Neisseria gonorrhoeae multiple-locus variable-number tandem-repeat analysis, N. gonorrhoeae Multiantigen sequence typing, and full-length porB gene sequence analysis for molecular epidemiological typing.Will Genome Analysis Elucidate Evolution, Global Transmission and Virulence of Neisseria Meningitidis Lineages?High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failureClonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track?In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatmIn vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeaeNeisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without cultureAnalytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis.Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae.The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.In vitro activity of the novel pleuromutilin lefamulin (BC-3781) and effect of efflux pump inactivation on multidrug-resistant and extensively-drug resistant Neisseria gonorrhoeae.Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland.Analytical specificity and sensitivity of the novel dual-target GeneProof Neisseria gonorrhoeae PCR kit for detection of N. gonorrhoeae.Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.High in vitro activity of a novel dual bacterial topoisomerase inhibitor of the ATPase activities of GyrB and ParE (VT12-008911) against Neisseria gonorrhoeae isolates with various high-level antimicrobial resistance and multidrug resistance.Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea?Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden.Analytical specificity and sensitivity of the APTIMA Combo 2 and APTIMA GC assays for detection of commensal Neisseria species and Neisseria gonorrhoeae on the Gen-Probe Panther instrument.In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates.Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015.
P50
Q33562762-89449714-E0BA-462A-B1D1-1A3E000A7CD0Q33797845-F8502E59-DC8A-41AD-A5C0-991590C39265Q34057315-9349A0D2-CB31-429C-BA97-F4851BC48598Q34123726-A0E76001-4EFD-432B-9902-77607A82BC72Q34513546-CB9B1F8C-D41D-4565-9387-D2762204F149Q34561067-F6C01B19-D7FE-48E3-BB58-BA265C743793Q34563908-786C6721-675D-41D9-8AC9-1FCDDB13AE44Q35047954-CED38B82-C3F2-4D37-B8C2-6DD6D0CDCEBBQ35065794-00350008-3D2F-4696-BDCF-C5F215AC3352Q35087427-0E75B1B0-3A2B-4E50-A341-BD22BCF77DAFQ35219997-99CF62D8-667E-498E-AAA5-EA4FD8996D33Q35668294-70E7C44A-D883-4B7E-A4D6-42A0CF875C5EQ35795084-3125289B-0B31-4F87-BBC3-20E2CED593CCQ35806206-9CC4505A-FEE0-4FA2-9768-CAF5DFC78E89Q35806407-8B59F38B-510C-419F-A1F2-EF39947D2060Q35904738-EF39AE8D-68D3-4D40-845E-DDC346B6C033Q35941481-8BA33C31-C264-4A6A-9FD4-39856AE0C18CQ36086360-60A42B15-5442-4548-9472-D70C3C96DC21Q36297569-8C1690E8-4998-4604-8055-C68E6F0B2FA7Q36360329-2ACBBFDF-B7FC-4FA1-82B8-2D3C164E644FQ36558447-F67D9D6F-E038-4609-B300-835EB7FB3EB0Q36800449-B69EBA71-F5BC-48E1-91EB-D0520C2A0AFBQ37026425-D49AB537-662F-4AEB-B102-9A69927B44A3Q37839330-F522C1DE-00CA-49B7-868B-FFDBE02098BAQ38652213-729319D3-B7A7-4A44-90C6-D2EDDA869FEBQ38840235-C896EAEB-3071-4873-A0E3-3308FA747C70Q40052692-94A8E3ED-AC7D-45FC-BB9E-10AACEDFD52DQ40160892-67D47507-5BB8-4A0B-AFBB-C43D6C2765DDQ40582231-EEF8C2AF-AB6F-4376-9218-620A24147BB2Q41571565-D4C7B4BC-1FF2-44B8-85CC-A50D26DCF3A3Q41757524-B8CE785C-ED36-4790-9A7C-C6FAED45A90CQ42202245-3FED226E-66B3-4400-B1CE-789C85CD5E62Q42222956-5DD26EEE-B30A-47BB-B8A8-4C92127CEA4AQ42228002-D45D5AFC-DC0B-415C-815D-82B91D1EA32DQ42693691-C17D6986-9F96-4255-9361-DF3835E3F6ECQ42861097-0C488AFF-B9C4-413B-8F8C-6E4D934D0765Q44538354-3A4EB8EF-4D4D-40C8-B3AD-0228DB0074DCQ45284769-DDE3044C-6C8C-4B5B-8156-ADD15DEF6911Q47607878-2E4F9718-A6FD-4EC6-8B37-B936A2C9B80EQ48537471-EAE89A00-5BC2-4F28-B817-A3AEC993FC1E
P50
name
Daniel Golparian
@en
type
label
Daniel Golparian
@en
prefLabel
Daniel Golparian
@en